The company declared an interim dividend of ₹75 per equity share, which reflects a 750% payout on shares carrying a ₹10 face value. Shareholders had until November 4 to purchase equity to meet the November 5 record date requirement. Combining this distribution with a previously declared ₹48 payout pushes the firm's trailing 12-month total to ₹123 per share, translating to an approximate 3.64% trailing yield.
Key points
Recent short-term price momentum has pushed the stock up 13.14% over the preceding week a…: Recent short-term price momentum has pushed the stock up 13.14% over the preceding week and 11.44% across the past month.
Long-term equity performance remains deeply negative, evidenced by a steep decline of 58.…: Long-term equity performance remains deeply negative, evidenced by a steep decline of 58.39% across a five-year holding period.
Year-to-date returns currently sit at negative 17.40%, trailing a broader one-year drop o…: Year-to-date returns currently sit at negative 17.40%, trailing a broader one-year drop of 28.75% for equity holders.
Sources checked by our analysis pipeline: 1
Sanofi India dividend 2026: Sanofi India share price is likely to remain in focus on Wednesday, November 4, as it is the last day for investors to buy the stock to qualify for the company's FY27 interim dividend.
Sanofi India announced an interim dividend of ₹75 per equity share for the financial year 2026, offering another payout to its shareholders. The pharmaceutical company declared the dividend following a board meeting held on October 29.
The dividend represents a payout of 750% on the face value of ₹10 per equity share. Sanofi India has fixed November 5, 2026, as the record date for determining eligible shareholders.
Sanofi India declared an interim dividend of ₹75 per equity share, having a face value of ₹10 each, for the financial year 2026. The company announced the payout on October 29, 2026, and has set November 5, 2026, as the record date.
Investors holding Sanofi India shares in their demat accounts as of the record date, subject to applicable settlement timelines, will be eligible to receive the dividend.
Investor appetite for corporate debt remains exceptionally strong as tech giants tap capital markets for massive funding rounds. The company saw overwhelming demand that vastly outstripped the issuance, allowing it to lock in substantial liquidity. This significant transaction provides substantial financial flexibility as the firm executes on its larger international financing strategy.
India's premier bourse delivered strong bottom-line expansion in its inaugural post-listing earnings report, buoyed by heightened trading activity across both cash and equity options segments. Strategic moves, including plans to divest a significant minority stake in its coal exchange subsidiary, have further cemented institutional confidence. Global and domestic analysts are elevating their valuation targets based on structural volume growth and forthcoming regulatory adjustments.
Public market entries on the BSE SME platform on November 4 provide fresh capital expansion for both businesses following distinct subscription phases in late October. Investors showed starkly different levels of appetite, heavily backing automation equipment while offering measured support for infrastructure. Both firms intend to deploy their raised funds primarily toward balance sheet deleveraging alongside targeted operational spending.